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We prepared hybrids consisting of Angelica gigas Nakai (AGN) root or flower extract
and layered double hydroxide (LDH) for potential anticancer nanomedicine, as decursin
species (DS) in AGN are known to have anticancer activity. Dimethylsulfoxide solvent
was determined hybridization reaction media, as it has affinity to both AGN and LDH
moiety. In order to develop inter-particle spaces in LDH, a reversible dehydration-
rehydration, so-called reconstruction route, was applied in AGN-LDH hybridization.
Quantitative analyses on AGN-LDH hybrids indicated that the content of DS was two
times more concentrated in the hybrids than in extract itself. Using X-ray diffraction,
FT-IR spectroscopy, scanning electron microscopy, and zeta-potential measurement,
we found that AGN extract moiety was incorporated into inter-particle spaces of LDH
nanoparticles during the reconstruction reaction. Time-dependent DS release from
hybrids at pH 7.4 (physiological condition) and pH 4.5 (lysosomal condition) exhibited a
pH-dependent release of extract-incorporated LDH hybrids. An anticancer activity test
using HeLa, A549, and HEK293T cells showed that the AGN-LDH hybrid, regardless of
extract type, showed enhanced anticancer activity compared with extract alone at an
equivalent amount of DS, suggesting a nanomedicine effect of AGN-LDH hybrids.
Keywords: layered double hydroxide, Angelica gigas Nakai, anticancer activity, decursin species, nanobiohybrid,
phytochemical
INTRODUCTION
Herbal medicine containing diverse bio-active phytochemicals have long been utilized (Kesarwani
and Gupta, 2013; Baumann, 2014). Recently, medicinal researchers have tried to find out
therapeutic single component (Lim et al., 2001); however, several studies suggested that whole
extract rather than single component is advantageous in therapies as complicated components
stimulate multiple targets, induce synergetic effect and act as bio-enhancers (Hu et al., 2009).
Therefore, improved drug efficacy could be envisaged with the less-purified extract (Lee et al., 2009;
Rasoanaivo et al., 2011).
Angelica gigas Nakai (AGN), one of the herbal crops widely distributed in eastern Asia, has
long been utilized as a herbal medicine source. Its root extract in particular has been utilized to
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treat anemia, hypertension, arthritis, menstrual disorders, etc.
(Suzuki et al., 2002; Song et al., 2004; Circosta et al., 2006; Guo
et al., 2007; Kil et al., 2008). According to recent researches, roots,
stems, and leaves of AGN contain bio-active substances such as
pyranocoumarins (decursin, decursinol angelate, prantschimgin,
angelinol, agasyllin, etc.), flavonoids, polysaccharides, phenolics,
and volatile aromatics (Zhang et al., 2012). We verified in our
previous study that the flowers of AGN, which have not been
utilized previously as a herbal medicine resource, are also rich
in antioxidants, such as phenolic acids and flavonoids (Kim
et al., 2015). Among those phytochemicals, the decursin species
(DS: decursin and decursinol angelate) have been shown to have
excellent anticancer activity in prostate cancer (Jiang et al., 2006;
Guo et al., 2007). Similar to other herbal medicine-based studies,
DS administered with other extract components showed higher
anticancer efficacy on lung and prostate cancers compared with
DS only (Lee et al., 2009).
In this sense, a natural extract containing bio-active substances
and bio-enhancers is expected to show improved drug efficacy
over purified single molecules. However, there are still problems
with herbal medicine in that the content of active substances
responsible for the major functions is very low. According to our
previous study, a methanol extract of AGN root contains only
8.5 wt/wt% of antioxidant (phenolic acid and flavonone) and 0.2
wt/wt% of anticancer DS species (Kim et al., 2016). Thus, a high
dose of AGN extract would be required for practical application.
In order to overcome these drawbacks, strategies of
nanomedicine could be taken. Nanomaterials such as liposomes,
polymeric particles, dendrimers, and inorganic materials have
been utilized as nanomedicine vehicles. They can encapsulate
drugs using their appropriate internal spaces and adsorb drugs on
large surface to protect vulnerable molecules from external harsh
condition (Oh et al., 2006b). They can rearrange drug molecules
in their interior to modify solubility (Mohammed et al., 2004),
to improve bioavailability and to release drug in controlled
manner (Maincent et al., 1986; Kang et al., 2015). Especially,
pH responsive drug release is possible in several vehicles
utilizing nanomaterials’ pH-dependent properties (Kim et al.,
2007). Several nanomaterials were developed to deliver drug
molecules to target organs using surface modified nanomaterials
as targeting ligands (Oh et al., 2009). In this way, nanomedicine
can reduce the administration dose of drug molecules. Among
various nanomaterials, layered double hydroxides (LDHs),
which can characteristically encapsulate bio-active molecules in
their 2-dimensional interlayer space, are potential drug delivery
carriers. LDHs have a layer-by-layer stacked structure consisting
of a positive layer (M2+1−xM3+x(OH)2x+: ∼0.5 nm thickness,
hundreds of nanometers in diameter) and exchangeable anions
(An−x/n) (Rives, 2001). Interestingly, the interlayer space of
LDHs can be as small as 0.37 nm with an interlayer of NO3−
and be freely expanded to a few nanometers with bulky organic
species (Cavani et al., 1991; Rives, 2001). Thus, LDHs have been
reported to stabilize fragile biomolecules (Oh et al., 2006b),
to solubilize poorly water-soluble drugs (Berber et al., 2008),
to release incorporated drug moieties in a controlled manner
(Kang et al., 2015), and to transport massive amounts of drug
molecules into intracellular systems (Oh et al., 2006c). LDHs
have several more characteristic advantages as delivery carriers.
LDHs are mechanically more stable than organic-based carriers
like liposomes. They are less cytotoxic and more biocompatible
than the other nanoparticles such as iron oxides and carbon
nanotubes (Choi et al., 2009). They can be dissolved into simple
ions at weakly acidic condition (possibly lysosomal condition),
while organic carriers produce various sized residues upon
hydrolysis. In terms of natural extract incorporation, LDHs
can be effective in that (i) their interlayer nanospace and large
inter-particle space provide appropriate spaces for variously sized
natural extract molecules (Rives, 2001; Kang et al., 2015), and
(ii) positive layer charges have a high affinity for phytochemicals,
which usually have a negative charge or δ− sites (Rives, 2001;
Kim et al., 2016).
In this study, we encapsulated whole natural extract from the
root or flower of AGN into LDH nanomaterials. We tried to
incorporate most of the phytochemical substances of the natural
extracts into LDH nanomaterials, considering the bio-enhancer
function. In our previous study, we showed the possibility to load
extract moiety into LDH hybrids (Kim et al., 2016). However,
that hybrid contained quite low amount of active components
(DS), and thus it is strongly required to enhance DS content for
practical applications as anticancer nanomedicine. In this regard,
we designed encapsulation conditions to optimally concentrate
DS in LDH nanomedicine. Solvent conditions were carefully
selected in order to solubilize both hydrophilic and hydrophobic
natural extract molecules and to facilitate the incorporation of
the organic moieties such as carbohydrates, lipids, flavonoids, and
DS in AGN extract into LDH nanomaterials. The encapsulation
method was strategically chosen to maximize incorporation
efficiency and to enhance the affinity for cellular membranes.
LDHs can undergo a reversible dehydration-rehydration process,
called reconstruction (Hibino and Tsunashima, 1998). Thermal
treatment of LDH nanomaterials at ∼400◦C produces a mixed
metal oxide that can recover the original LDH structure in
the presence of water and anionic species to be encapsulated
(Nyambo et al., 2009). This encapsulation strategy forms particle
nanostructures that are less crystalline and highly interconnected,
resulting in inter-particle space, which can accommodate various
organic substances (Kang et al., 2015), while the external surface
of an organic-LDH hybrid possesses a positive charge for effective
interactions with negative cellular membrane (Oh et al., 2006a).
The goal of this study is to investigate the structure of the
obtained hybrid nanomedicine and to evaluate their potential
for anticancer treatment. In this regard, DS concentration effect
and controlled release by LDH nanomaterials were investigated
and the anticancer properties of the hybrid nanomedicines were
evaluated in several cancer cells.
MATERIALS AND METHODS
Materials
Root and flower extracts of Angelica gigas Nakai (AGN) were
provided by the National Institute of Horticultural and Herbal
Science in Korea. Magnesium nitrate hexahydrate [Mg(NO3)2·
6H2O], aluminum nitrate nonahydrate [Al(NO3)3·9H2O],
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sodium bicarbonate (NaHCO3), and dimethylsulfoxide (DMSO)
were purchased from Sigma-Aldrich Co. LLC. (St. Louis, MO,
United States). A standard decursin sample for chromatography
was purchased from ChromaDex Inc. (Irvine, CA, United States).
Sodium hydroxide (NaOH), n-hexane, and chloroform were
acquired from DAEJUNG CHEMICALS & METALS CO.
LTD. (Siheung, South Korea). Methanol (Burdick & Jackson R©,
Morristown, NJ, United States) and acetone (SAMCHUN
CHEMICAL CO., Yeosu, South Korea) were used to solubilize
AGN extract solid. Hanks’ balanced salt solution (HBSS) was
obtained from WELGENE Inc. (Taipei, Taiwan). Phosphate
buffered saline (PBS) was acquired from Lonza (Walkersville,
MD, United States). All reagents were used without further
purification.
Solubility of DS in Various Solvents
Dried AGN extract (200 mg), which was previously extracted
in methanol at 25◦C and dried by vacuum evaporation at
60◦C, was dissolved in six different solvents (100 mL) including
deionized water (DW), methanol, DMSO, acetone, n-hexane,
and chloroform. The DS content in each solution was quantified
by high performance liquid chromatography (HPLC, Yonglin
YL9100 Series, Anyang, South Korea). The mobile phase was an
acetonitrile:DW (6:4) mixture with a flow rate of 0.8 mL/min, and
a UV-Vis detector with a wavelength of 350 nm was used.
Preparation of Pristine LDH (MgAl-LDH)
and Its Calcined Form
The pristine MgAl-LDH was prepared by a conventional
coprecipitation method followed by hydrothermal treatment,
as reported elsewhere (Kim et al., 2011). Mg(NO3)2·6H2O
(0.06 mol) and Al(NO3)3·9H2O (0.03 mol) were dissolved in
200 mL of DW, and the solution was titrated to pH ∼9.5 with
NaOH/NaHCO3 (0.23 mol/0.17 mol in 250 mL DW). Then, the
white suspension was transferred to a Teflon-lined autoclave and
put in an oven at 150◦C for 24 h. Finally, a white precipitate
(MgAl-LDH) was collected by centrifugation, thoroughly washed
with DW, and then lyophilized. In order to prepare the calcined
LDH, the MgAl-LDH powder was put in an alumina boat
and thermally treated at 400◦C in an electric muﬄe furnace
for 9 h.
Preparation of AGN-LDH Hybrid by
Reconstruction
AGN extracts, both from root (RT) and flower (FL)
(27.1 mg and 36.6 mg, respectively), were dissolved in
1 mL of DMSO, and then 30 mL of calcined LDH in water
suspension (23 mg/mL) was added to the AGN/DMSO
solutions. After thorough mixing, 70 and 44 mL of DW
was added to the mixtures for RT and FL, respectively, to
reconstruct the LDH structure. The reactants were stirred
for 12 h in darkness. Then, the suspension was centrifuged,
washed with DW, and lyophilized. The obtained hybrids
were designated as RT-LDH and FL-LDH for AGN root
extract-incorporated hybrid and flower extract-incorporated
hybrid, respectively.
Characterization
The crystal structures of MgAl-LDH, its calcined form, and the
hybrids were investigated by powder X-ray diffraction (PXRD,
D2 Phaser with LYNXEYETM detector, Bruker AXS GmbH,
Kalsruhe, Germany) with Cu Kα radiation (λ = 1.5406 Å).
The ground powder samples were mounted on a poly(methyl
methacrylate) holder, and a diffraction pattern was obtained in
the 2θ range of 3–80◦ with scanning steps of 0.02◦. The chemical
property of MgAl-LDH, AGN extract and the hybrids was
confirmed by Fourier transform-infrared spectroscopy (FT-IR,
spectrum one B.v5.0 spectrometer, Perkin Elmer, Waltham,
MA, United States) utilizing conventional KBr method. The
morphology and particle size of MgAl-LDH, its calcined form,
and the hybrids were observed with field emission-scanning
electron microscopy (FE-SEM, Quanta 250 FEG, FEI, Hillsboro,
OR, United States). For the SEM measurement, the powder
samples were immobilized on carbon tapes and sputtered with
Pt/Pd for 30 s. For the zeta-potential measurement, 1 mg of
MgAl-LDH and each hybrid powder were dispersed in 1 mL DW,
and then the zeta-potential was measured by ELSZ-1000 (Otsuka,
Kyoto, Japan). The contents of AGN (RT or FL) in corresponding
hybrids were evaluated by measuring the weight difference of the
organic moiety before and after the hybridization reaction. DS
was quantified with HPLC as described above.
DS Release Study
In order to evaluate the amount of DS released from the hybrids,
50 mg of hybrid powder was dispersed into 100 mL of media
such as pH 7.4 PBS or pH 4.5 HBSS. At the determined time
point (5, 10, 15, 20, 25, 30, 60, 90, or 120 min), 1 mL of
suspension was collected, and the solid part was removed by
centrifugation at 8000 rpm and filtration with a 0.45-µm pore
syringe filter (Advantec Toyo Roshi Kaisha Ltd., Tokyo, Japan).
The fractional release of DS was quantified with an HPLC, as
described above. All experiments were performed in triplicate.
The observed time-dependent release was fitted with four kinds
of kinetic models including the first-order kinetic (Eq. 1), Elovich
model (Eq. 2), parabolic diffusion (Eq. 3), and power function
(Eq. 4), as shown below (Jalali, 2006; Shariatmadari et al., 2006).
First order lnQt = lnQe − k1t (1)
k1: first-order rate constant (h−1)
Elovich equationQt = a + blnt (2)
a: released quantity in the initial phase, b: release rate
Parabolic diffusionQt = Qe + Rt1/2 (3)
R: diffusion rate constant
Power functionQt = αtβ (4)
α: initial desorption rate constant, β: desorption rate
coefficient
Qt is the released amount after t min, and Qe is the released
amount at equilibrium for all models.
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Cell Culture
Human cervical adenocarcinoma cells (HeLa), human lung
adenocarcinoma epithelial cells (A549), human embryonic
kidney cells containing SV40 Large T-antigen (HEK293T),
and mouse myoblast cells (C2C12) were grown in DMEM
supplemented with 10% FBS and 1% penicillin/streptomycin in
a humidified atmosphere containing 5% CO2 at 37◦C.
Trypan Blue Assay of AGN Extracts and
AGN-LDH Hybrids
Anticancer activity of AGN extract and AGN-LDH hybrids was
evaluated by trypan blue assay. Conventional MTT assay was not
used because DS can disturb the absorbance of formazan in MTT
assay. Cells were seeded at a density of 2.0× 105 cells per well on
6-well culture plates. After 24 h of incubation, sample solutions
or suspensions (0.1% DMSO/serum-containing DMEM) were
added to the cells at pre-determined DS concentrations for
24 h. Then, cells were trypsinized and collected in PBS. After
centrifugation (100 g, 5 min), cell pellets were resuspended in
1 mL PBS and stained with 0.4% trypan blue solution for 2 min
at room temperature (Strober, 2001). The numbers of stained
dead cells and unstained viable cells among 200–300 cells were
counted with a hemacytometer each time. All experiments were
performed in triplicate.
RESULTS
Solubility of DS in Various Solvents
Table 1 displays the solubility of extracts and DS (Figure 1)
in various solvents. Dried AGN methanol extract was dissolved
in several solvents: polar protic solvents (water, methanol),
polar aprotic solvents (DMSO, acetone), and non-polar solvents
(n-hexane, chloroform) (Figure 1). In terms of dissolution
efficacy for total extract components, methanol, DMSO, and
deionized water showed excellent capacities. However, water did
not effectively solubilize DS. Considering both total extract and
DS dissolution, DMSO showed the best ability and thus was
selected as the hybridization reaction media.
Characterization of AGN-LDH Hybrids
The crystal structures of the two AGN-LDH hybrids, RT-LDH
and FL-LDH, were analyzed and compared with those of pristine
TABLE 1 | Dissolved extract and DS from 200 mg of Angelica gigas Nakai root
methanol extract.
Solvent type Extraction
solvent
Dissolved
extract (mg)
Dissolved
DS (mg)
Polar protic Deionized water 137 ± 39 2.5 ± 0.01
Methanol 202 ± 24 40.3 ± 0.54
Polar aprotic Acetone 76 ± 8.9 34.1 ± 0.59
Dimethylsulfoxide 192 ± 25 58.4 ± 7.48
Non-polar n-Hexane 57 ± 11 31.5 ± 0.62
Chloroform 61 ± 17 27.2 ± 0.68
DS, decursin species.
LDH and the extract itself by measuring powder X-ray diffraction
patterns (Figure 2). Pristine LDH showed sharp diffraction peaks
at 2θ values of 11.7, 23.5, 34.6, 38.5, 45.5, 60.8, and 62.2◦,
which could be assigned to (hkl) indexes of (003), (006), (012),
(015), (018), (110), and (113), respectively, showing the intended
hydrotalcite (JCPDS (Joint Committee on Powder Diffraction
Standards) card No. 14-0191) phase. Calcined LDH exhibited
(200) and (220) peaks at 2θ 43.3 and 62.5◦, suggesting the
evolution of MgO (periclase, JCPDS card No. 45-0946) upon
thermal treatment. In contrast, two kinds of extracts from RT
and FL showed an amorphous phase with some salt-like peaks in
XRD patterns. After hybridization, the crystal structure of LDH
was observed to be recovered, showing the (003), (006), (012),
(018), and (110) peaks of hydrotalcite. The decreased crystallinity
was attributed to random stacking of LDH nanolayers and large
organic moieties, implying the incorporation of extract inside the
LDH nanostructures (Kim et al., 2016).
The FT-IR spectrum of RT extract showed the characteristic
bands (dashed arrows) of polysaccharide and DS such as
α-pyrone ring (1717 cm−1), aromatic C=C (1632 and
1566 cm−1), C-O stretching (1226 cm−1) and aromatic
C-O (1136 and 1028 cm−1) (Figure 3A) (Li et al., 2014; Kim
et al., 2016). The characteristic peak of MgAl-LDH (solid arrow)
was exhibited at 1365 cm−1 (stretching vibration of interlayer
CO32−) and 790, 674 cm−1 (both for M-OH stretching of LDH).
After hybridization, all characteristic bands of RT extract and
MgAl-LDH were observed at similar peak position with RT and
MgAl-LDH. In case of FL extract, -OH bending of polysaccharide
and aromatic C-O stretching of DS were exhibited at 1664 cm−1
and 1117, 1029 cm−1, respectively (Figure 3B). IR spectrum of
FL-LDH hybrid indicated that the characteristic peak of FL and
MgAl-LDH were also preserved after hybridization.
Scanning electron microscopic (SEM) images showed
step-by-step morphological changes of LDH from pristine to
AGN-LDH hybrids. Pristine LDH (Figure 4a) exhibited particles
having a thick coin-like shape with thickness of ∼90 nm and a
diameter of∼244 nm, which corresponded to the hydrodynamic
radius, 255 nm, of MgAl-LDH (Supplementary Figure S1A).
Upon calcination, the thickness of the particle was reduced to
∼50 nm, while the diameter and shape were mostly maintained
(Figure 4b). After hybridization, the overall morphology of
particles changed significantly. Both RT-LDH and FL-LDH
hybrids demonstrated sand-rose shapes, in which very thin layers
were partially bent and agglomerated (Figures 4c,d). Although
the images for both hybrids seemed to have assembly of particles,
close observation exhibited that the primary particle size of
pristine LDH, RT-LDH, and FL-LDH hybrid were comparable
to each other showing 244, 241, and 239 nm (dashed circles in
Figure 4), respectively. The hydrodynamic radii of both hybrids
in aqueous suspension were 595 and 826 nm for RT-LDH
and FL-LDH (Supplementary Figures S1B,C), respectively,
suggesting the possibility of agglomerate with two or three
particles in hybrids.
Surface charges of pristine LDH, AGN extract, and hybrids
were investigated by measuring their zeta potentials in an
aqueous media of pH ∼7.0. As shown in Figure 5, pristine
LDH was determined to have a high positive surface charge of
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FIGURE 1 | Molecular structures of DS and secondary extraction solvents. DS, decursin species.
FIGURE 2 | Powder X-ray diffraction patterns of (A) MgAl-LDH, (B) calcined
LDH, (C) root extract powder, (D) flower extract powder, (E) RT-LDH hybrid,
and (F) FL-LDH hybrid. LDH, layered double hydroxide; RT, root; FL, flower.
∼+38.5 mV, and the distribution of zeta potential lay in the range
of+10∼+75 mV (solid line). Different from pristine LDH, zeta
potential values of both AGN extracts (RT and FL) showed strong
negative charges centered at ∼−75.6 mV, and the distribution
was from −50 to −130 mV. After hybridization, zeta potential
value again shifted to the positive region. For both hybrids, the
distribution lay between 0 and +50 mV with an average value of
+26.7 mV.
Table 2 displays the DS quantification results of the hybrids.
First, the extract content was 18.4 and 16.1 wt/wt% for RT-LDH
and FL-LDH hybrids, respectively. The content of DS was 11.5
and 2.23 wt/wt% for RT-LDH and FL-LDH hybrids, respectively.
DS content in the original extracts was 30.8 and 6.27 wt/wt%
in AGN root and flower, respectively. When we estimated DS
content in total extract inside hybrids, they were much larger than
those in the original extract, 62.8 wt/wt% and 13.8 wt/wt% for
RT-LDH and FL-LDH, respectively.
Evaluation on DS Release From Hybrids
Time-dependent release profiles of DS from hybrids in either
neutral physiological condition (pH 7.4 PBS) or lysosomal
condition (pH 4.5 HBSS) are displayed in Figure 6. RT-LDH
slowly released the DS in pH 7.4 PBS, and the cumulative release
reached ∼6.1% after 120 min (Figure 6A). In contrast to the
release profile in pH 7.4 PBS, RT-LDH in pH 4.5 HBSS showed
fast release at the early stage (0–25 min), followed by slow and
sustained release. The cumulative DS release was almost 35% at
120 min, and the initial burst of DS before 25 min was responsible
for ∼30% of the total release (Figure 6A). The FL-LDH hybrid
showed similar patterns with RT-LDH both in pH 7.4 PBS and
pH 4.5 HBSS with more suppressed DS release (Figure 6B). The
cumulative DS release in the early stage before 25 min was ∼1.0
and 11% in pH 7.4 PBS and pH 4.5 HBSS, and the cumulative
release at 120 min was∼2.1 and 18%, respectively.
The release profiles were fitted to several well-established
kinetic models, such as first order, Elovich, parabolic, and power
function equations, and their fitting results are summarized in
Table 3. DS release patterns of RT-LDH and FL-LDH hybrids
in pH 7.4 PBS and pH 4.5 HBSS were well-fitted to the Elovich
model, showing coefficient of determination R2 values larger than
0.98 except pH RT-LDH in pH 4.5 HBSS. Although RT-LDH in
pH 4.5 HBSS media showed a relatively lower R2 value of 0.8451,
the Elovich model was determined to be the most reasonable
kinetic model among the fitted models in terms of R2 value.
The Elovich parameters, a and b, for two AGN-LDH hybrids
in PBS and HBSS conditions are summarized in Table 4.
Parameter a is related to the release in the initial phase; a higher
a value is related to a larger amount of initial release (Mengel,
2000). Parameter b stands for the release rate of a loaded moiety
(Jalali, 2006). RT-LDH showed an initial burst effect in pH 4.5
HBSS (a = 6.21), while its release in the early stage was suppressed
in pH 7.4 PBS (a = −0.0539). The release rate of RT-LDH was
higher in HBSS condition (b = 3.26) than in the PBS (b = 0.738).
For FL-LDH, the parameter a was similar to each other in both
types of release media, while the release rate of FL-LDH was
higher in pH 4.5 HBSS (b = 0.509) than in the pH 7.4 PBS
(b = 0.00784). Compared with RT-LDH, the initial DS release
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FIGURE 3 | Fourier transform-infrared spectra of (a) MgAl-LDH, (b) extract and (c) hybrid for (A) RT-LDH and (B) FL-LDH hybrid. LDH, Layered double hydroxide;
DS, Decursin species; RT, Root; FL, Flower.
FIGURE 4 | Scanning electron microscopic images of (a) MgAl-LDH, (b) calcined LDH, (c) RT-LDH hybrid, and (d) FL-LDH hybrid. Dotted circles stand for primary
particles. LDH, layered double hydroxide; RT, root; FL, flower.
from FL-LDH was fairly suppressed (a = 6.21 and −0.407 for
RT-LDH and FL-LDH in HBSS media, respectively), and the
release rate was very slow (b = 0.00784 and 0.509 for PBS and
HBSS).
Anticancer Efficacy of AGN-LDH Hybrids
Anticancer efficacy of AGN-LDH hybrids was examined in
A549, HeLa, and HEK293T cells by trypan blue assay. C2C12
myoblast cells were used as a control. Hybrid sample suspensions
were treated based on DS concentration, which was calculated
according to the pre-quantified DS content in hybrids. According
to the preliminary test, 0.1% DMSO/DMEM solution was found
to be non-cytotoxic. As shown in Figure 7, AGN extracts from
both FL and RT displayed low cancer cell-killing activities.
Less than 10% of A549 cells and somewhat more HeLa and
HEK293T cells (about 10–20%) were found to be dead at a high
DS concentration of 50 µM. However, DS-containing hybrids
(FL-LDH and RT-LDH) exhibited much higher cancer cell-
killing activities in all cell types than did the AGN extract.
Above 20 µM, more cancer cells were found to be dead in the
hybrid-treated condition than in the AGN extract only treated
condition. Furthermore, RT-LDH showed a higher anticancer
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FIGURE 5 | Zeta-potential graphs of AGN-LDH hybrids. (A) RT-LDH hybrid and (B) FL-LDH hybrid. Solid line: MgAl-LDH, dashed line: AGN extract, open circles:
AGN-LDH hybrids. AGN, Angelica gigas Nakai; LDH, layered double hydroxide; RT, root; FL, flower.
TABLE 2 | Loading capacity and DS content for AGN extract and DS in AGN-LDH
hybrids.
Extract loading
capacity in hybrid
[extract/hybrid
(wt/wt%)]
DS loading
capacity in hybrid
[DS/hybrid
(wt/wt%)]
DS content in
total extract
[DS/extract
(wt/wt%)]
Root extract – – 30.8 ± 0.12
Flower extract – – 6.27 ± 0.13
RT-LDH 18.4 ± 1.28 11.5 ± 0.05 62.8 ± 4.28
FL-LDH 16.1 ± 0.08 2.23 ± 0.004 13.8 ± 4.73
AGN, Angelica gigas Nakai; DS, decursin species; LDH, layered double hydroxide;
RT, root; FL, flower.
activity than FL-LDH in all cell types, with about 40–50% of
cancer cells killed at 50 µM in the RT-LDH-treated condition.
Interestingly, RT-LDH, and FL-LDH showed low dead cells
population (<20%, even at high concentration of 50 mM DS) in
C2C12 cells, similarly with root and flower extract (Figure 7D).
DISCUSSION
According to the solubility test (Table 1), the organic moieties in
the AGN extract including DS can be effectively dissolved
utilizing polar aprotic DMSO (Figure 1). Amphiphilic
DMSO, which has both hydrophobic (two methyl groups) and
hydrophilic (sulfoxide group) groups, was expected to effectively
dissolve both hydrophilic and hydrophobic chemical species in
the extracts. Furthermore, DMSO can facilitate effective reactions
between hydrophobic DS and hydrophilic LDH nanomaterials.
Thus, DMSO was selected as the hybridization media. The
extract/DMSO solutions were determined to have 30.8 and 6.27
wt/wt% of DS for AGN root and flower, respectively, providing
contents that were sufficiently high to utilize DS as active
components in the anticancer study after hybridizing with LDHs.
Physicochemical analyses such as XRD, FT-IR, SEM, and zeta
potential measurement showed that the hybrids possessed AGN
extract inside the nanostructures formed by LDH nanoparticles.
According to XRD patterns (Figure 2), FT-IR spectra (Figure 3),
and SEM images (Figure 4), we conclude that the organic
moieties in the AGN extract were incorporated into the LDH
nanostructure during the reconstruction process. Crystallinity
reduction and peak shift to a lower angle in the hybrid compared
with in the pristine LDH indicated that the organic moieties were
incorporated. Generally, LDHs undergo partial lattice distortion
and re-organization during a reconstruction process (Pérez-
Ramírez et al., 2007; Martínez-Ortiz Mde et al., 2008), and this
distortion and re-organization could be more significant when
large organic molecules, such as those from natural extract, were
incorporated (Kim et al., 2016). Diffraction patterns of AGN,
both amorphous patterns in the 2θ range 5–30◦ and several small
and sharp peaks, disappeared after hybridization, confirming that
FIGURE 6 | Release patterns of DS from (A) RT-LDH hybrid and (B) FL-LDH hybrid in pH 7.4 PBS and pH 4.5 HBSS. DS, Decursin species; RT, Root; FL, Flower;
LDH, Layered double hydroxide; PBS (), Phosphate buffered saline; HBSS (©), Hanks’ balanced salt solution.
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TABLE 3 | Linear regression results of time-dependent DS release pattern from RT-LDH and FL-LDH nanohybrids for kinetic model fitting.
Kinetic model Regression equation R2
RT-LDH/pH 7.4 PBS First order lnQt = −1.834 × 10−4 t − 0.008964 0.6988
Elovich equation Qt = 0.7376 lnt − 0.05392 0.9950
Parabolic diffusion Qt = 5.525 × 10−3 t1/2 + 0.007202 0.9338
Power function lnQt = 0.3219 lnt − 0.2413 0.9837
FL-LDH/pH 7.4 PBS First order lnQt = −7.173 × 10−5 t − 0.001484 0.8832
Elovich equation Qt = 7.842 × 10−2 lnt − 0.1416 0.9897
Parabolic diffusion Qt = 2.136 × 10−3 t1/2 + 0.001714 0.9678
Power function lnQt = 0.6956 lnt − 4.614 0.9193
RT-LDH/pH4.5 HBSS First order lnQt = −9.354 × 10−3 t − 0.5852 0.5831
Elovich equation Qt = 3.256 lnt + 6.210 0.8451
Parabolic diffusion Qt = 4.314 × 10−2 t1/2 + 0.5687 0.6766
Power function lnQt = 0.1992 lnt + 2.154 0.8132
FL-LDH/pH4.5 HBSS First order lnQt = −2.105 × 10−3 t − 0.1221 0.8898
Elovich equation Qt = 0.5092 lnt − 0.4070 0.9920
Parabolic diffusion Qt = 4.330 × 10−2 t1/2 + 0.1127 0.9368
Power function lnQt = 0.3917 lnt − 1.106 0.9645
DS, decursin species; RT, root; FL, flower; LDH, layered double hydroxide; PBS, Phosphate buffered saline; HBSS, Hanks’ balanced salt solution.
the molecular arrangement of the AGN extract was re-organized
by host LDH nanostructures. Through FT-IR spectra, organic
moieties such as carbohydrate and DS in both extract preserved
their intact structure after hybridization. The hydrodynamic
radii (Supplementary Figures S1B,C) and primary particle size
(Figures 4c,d) of both hybrids showed that several LDH particles
might be assembled without serious aggregation. A sand-rose
morphology consisting of randomly stacked layers of LDH was
also found in a previous study when organic moieties of a
natural extract were incorporated into LDH nanostructures (Kim
et al., 2016). Random stacking of thin LDH layers (∼19.4 nm
thickness from Figure 4) could form pores able to accommodate
the extract. Zeta potential results also supported the conclusion
that AGN extract was trapped inside the nanostructures. Zeta
potential values of both RT-LDH and FL-LDH were close to
those of pristine LDH, showing positive values (Figure 5). If the
AGN extract covered only the surfaces of LDH nanostructures,
the surface charge of the hybrids would be closer to that of
AGN extract. Thus, we suggest that LDHs accommodated organic
moieties inside the inter-particle pores rather than at its surface.
Although LDH can accommodate negatively charged molecules
in its interlayer space, we excluded this possibility because the
XRD pattern of the hybrid (Figure 2) did not show significant
interlayer expansion [(003) peak position].
The contents of AGN extract in the hybrid were 18.4 and 16.1
wt/wt% for RT-LDH and FL-LDH, respectively. These contents
were larger than those reported in our previous study, where
we incorporated AGN root extract into LDH utilizing methanol
solvent (Kim et al., 2016). We are fairly sure that the DMSO
solvent played an important role in AGN incorporation; it did
not only solubilize as much AGN as possible but also guided them
to the LDH nanostructure resulting in efficient hybridization. It
was worthy to note that the DS content of extract in hybrids
was dramatically enhanced compared with the DS content in
the extract itself, showing 62.8 and 13.8 wt/wt% in RT-LDH
TABLE 4 | Parameters obtained from kinetic fitting results of the Elovich equation
for the release of DS from AGN-LDH hybrids in pH 7.4 PBS or pH 4.5 HBSS.
a b
RT-LDH in pH 7.4 PBS −0.0539 0.738
RT-LDH in pH 4.5 HBSS 6.21 3.26
FL-LDH in pH 7.4 PBS −0.142 0.00784
FL-LDH in pH 4.5 HBSS −0.407 0.509
DS, decursin species; AGN, Angelica gigas Nakai; LDH, layered double hydroxide;
PBS, Phosphate buffered saline; HBSS, Hanks’ balanced salt solution; RT, root;
FL, flower.
and FL-LDH hybrids, respectively. This result indicates that
62.8% of total organic moiety in the RT-LDH hybrid (13.8% for
FL-LDH) was DS, which has anticancer activity. Therefore, we
expect that both hybrids would exhibit high anticancer efficacy as
nanomedicines.
Both hybrids showed DS release patterns fitted to the Elovich
model, which explained adsorption or desorption of adsorbate
mediated by bulk surface diffusion. According to the literature,
organic molecules encapsulated in LDHs followed the power
function model, which hypothesized release mediated by flat
surface diffusion or ion exchange (Kang et al., 2015). The Elovich
model in this study suggested that the DS moiety was located
in the 3-dimensional inter-particle space rather than being
arranged in the flat interlayer space. This point is important for
anticancer drug release from nanoparticles as the arrangement
affects drug release kinetics. When drug molecules are located
as a quasi-bulk state in large inter-particle pores as in current
sample, a large amount of drug moiety can be easily released to
act as anticancer agents. Thus, incorporation of DS moieties in
the inter-particle space in the present hybrids and Elovich release
could be advantageous to anticancer nanomedicine. It was also
noteworthy that the both RT-LDH and FL-LDH hybrids showed
enhanced drug release in pH 4.5 HBSS solution, which simulates
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FIGURE 7 | Trypan blue assay of AGN extracts and AGN-LDH hybrids in (A) A549, (B) HeLa, (C) HEK293T, and (D) C2C12 cells. X-axis means DS concentration.
AGN, Angelica gigas Nakai; LDH, layered double hydroxide.
the lysosomal condition in cancer cells. In this condition, LDH
can be partially dissolved into simple ions, thus release of loaded
drug is accelerated. As it is known that drug-LDH hybrids
are internalized into cells via endocytosis (Oh et al., 2006a),
lysosomal escape of DS moiety from both RT-LDH and FL-
LDH hybrids is expected with increased DS amount compared
with simulated physiological condition (PBS). FL-LDH show
suppressed DS release amount in both pH 7.4 PBS and pH
4.5 HBSS compared with RT-LDH, possibly due to the higher
organic moieties content in FL-LDH than in RT-LDH (13.8%
DS and 86.2% of other organic moieties, respectively, in FL-LDH
compared with 62.8% DS and 37.2% in RT-LDH). Major organic
components such as lipid, carbohydrate, etc. are thought to trap
DS moiety and retard its release. Nevertheless, we conducted
anticancer assays for both hybrids, expecting enhanced DS release
from the both hybrid in lysosomal condition.
From the literature, DS is known to inhibit cell cycle
progression and induce apoptosis in human prostate and
murine colon cancer cells (Yim et al., 2005; Son et al.,
2011). In addition, decursin and decursinol angelate have been
reported to have anti-cancer effects against human cervical
cancer cells but not lung cancer cells (Yim et al., 2011). We
used human cervical (HeLa), lung (A549), and embryonic
kidney cancer cells (HEK293T) for this assay in order to
examine the anti-cancer activity of decursin-containing AGN-
LDH hybrids on various cell types. Anticancer efficacy test
results (Figure 7) showing higher percentages of dead cells
for treatment with hybrids than for extract only, could be
easily explained by a more efficient cellular uptake mechanism
and facilitated release of DS in the lysosomal condition. Anti-
proliferating activity of AGN-LDH was also examined in C2C12
myoblast cells (Figure 7D). It was known that non-transformed
“normal” cells were less sensitive to DS. This low cytotoxicity
of AGN-LDH in C2C12 cells displays its safety to normal
cells. Extracts showed relatively high anti-cancer activity in
HeLa cells compared with A549 cells, which is consistent with
the results of a previous report (Yim et al., 2011). However,
interestingly, LDH hybrids showed significant anticancer activity
in all cell lines, depending on the concentration used. Decursin
species in extract (closed circles in Figure 7) are thought to
penetrate the cell membrane by passive diffusion or facilitated
transport. However, DS can massively enter cancer cells via LDH-
assisted endocytosis and can be released to the cytosol from
LDH in acidic lysosomal conditions. In addition, A549 cells
result suggests that cytosolic delivery of DS by encapsulation
into LDH nanocarriers also may avoid cellular eﬄux system,
contrary to DS only. It should be noted that the amounts
of DS in both hybrid and extract were set to be almost the
same, and that LDH itself is known to be highly compatible
with various cancer cell lines (Choi et al., 2007, 2009).
In Supplementary Figure S2, minimal cytotoxicity of LDH
itself was also confirmed by MTT assay. Thus, the enhanced
anticancer efficacy of hybrids was thought to be attributed to
the hybridization of DS with LDHs, as reported previously
for drug-LDH hybrids (Oh et al., 2006c; Kim et al., 2013,
2014), and this study verified that the drug-LDH strategy as a
nanomedicine can be applied to a natural extract. The fate of
LDH, during and after delivering therapeutic agents to cells, is not
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fully comprehended; however, we can suggest several processes
according to the literatures. In our previous work based on
electron microscopy (tracing LDH part) and confocal microscopy
(tracing encapsulated drug molecules), drug encapsulated LDH
enters cell, releases drugs to the cytosol and is excreted out of the
cell after 24 h (Oh et al., 2011). The other literature also reported
that LDHs could be taken up by cells through endocytosis and
finally exocytosed depending on particle size (Chung et al., 2012).
The report also claimed that LDH particles could be degraded
in lysosome which fused with LDH-containing endosome. To
summarize, once entered LDH undergoes partial degradation
and exocytosis. Between the two hybrids investigated, RT-LDH
showed higher cancer cell suppression effects than did FL-LDH,
even though the same quantities of DS were present in both
hybrids. This result can be explained by the release behaviors;
RT-LDH exhibited ∼35% release within 120 min, while FL-LDH
released ∼18% in this same amount of time. Thus, facilitated DS
release from RT-LDH in the lysosomal condition is thought to
induce effective anticancer activity.
CONCLUSION
We prepared hybrids between LDH and AGN root or flower
extract containing DS, anticancer phytochemicals, via the
reconstruction route. In order to effectively solubilize DS and
to facilitate hybridization with LDH, polar aprotic DMSO
solvent was used. According to the XRD patterns, FT-IR
spectra, SEM images, and zeta potential values, the AGN-LDH
hybrid possessed AGN extract inside the nanostructured
pores developed by random stacking of LDH nanoparticles.
Quantitative analyses revealed that 15–20 wt% of extract was
incorporated into AGN-LDH hybrids, and DS in AGN-LDH
hybrid was twice as concentrated as that in AGN extract itself.
The release profiles of both AGN-LDH in pH 7.4 PBS and
pH 4.5 HBSS fitted well with the Elovich equation, indicating
bulk surface release, suggesting that the DS located in the
inter-particle pore of LDH was released in a bulk surface
manner. Cell viability tests by trypan blue assay in cancer cells
demonstrated the dramatically enhanced anticancer activity of
the AGN-LDH hybrid compared with AGN itself. Between
the two hybrids examined, RT-LDH was determined to have
higher anticancer activity than FL-LDH, and this difference was
attributed to the facilitated DS release from RT-LDH in the
lysosomal condition.
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